Mental Health
Feature
Novel antidepressant shines in phase 2 trial, but FDA has issues with its NDA
In the MERIT study, AXS-05 significantly delayed time to depression relapse compared with placebo, which was their primary endpoint.
From the Journals
Opioid prescribing laws having an impact
The number of days an opioid was prescribed for each Medicare beneficiary decreased by 11.6 days in 2018 in states that imposed duration limits....
Commentary
Clinical pearls for Muslim patients with suicide risk
Our research shows that discrimination and marginalization, both religious and racial, are prominent suicide risk factors in the American Muslim...
From the Journals
‘Munchausen by Internet’ crises a warning for all HCPs
“The ease of carrying out Munchausen behaviors makes me think that it must be much more common than it ever was,” said Dr. Marc Feldman.
Commentary
Reckoning with America’s alarming rise in anti-Asian hate
If we do nothing, communities and groups will continue to suffer the effects of racial hatred, said Dr. Lorenzo Norris.
Commentary
The Surfside tragedy: A call for healing the healers
The days right after the collapse were agonizing for all as we waited and hoped for survivors to be found, said Dr. Eva Ritvo.
Feature
Mental illness admissions: 18-44 is the age of prevalence
Schizophrenia, depression, bipolar, and alcohol use disorders among the top five primary diagnoses for stays in younger adults.
Commentary
COVID-19, hearings on Jan. 6 attack reignite interest in PTSD
Dr. Elspeth Cameron Ritchie says she counsels patients with PTSD about “three buckets” of treatment.
Opinion
Obesity treatment in mental illness: Is semaglutide a game changer?
Maybe it’s time for psychiatrists to prescribe medications that prevent weight gain, Dr. Dinah Miller says.
From the Journals
PUFAs a promising add-on for borderline personality disorder
Adjunctive omega-3 fatty polyunsaturated fatty acids significantly reduce overall BPD symptom severity, a meta-analysis of four RTCs shows.
Commentary
MDs rebut claims of toxic culture after resident suicides
Dr. Pamela Wible “misrepresented our residency program and made numerous statements that are false and simply hurtful,” [Dr. Dimitrov and Dr....